Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Passik
Lynn Webster

Journal of opioid management

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Opioid Management|August 28, 2014
Opioid analgesics: does potency matter?Steven D Passik, Lynn Webster
Journal of Opioid Management|August 10, 2011
Current status and evolving role of abuse-deterrent opioids in managing patients with chronic painLynn Webster, Barbara St Marie, Bill McCarberg, et al.
Journal of Opioid Management|December 15, 2011
A comparison of methods of administering the opioid risk toolTed Jones, Steven D Passik
Journal of Opioid Management|February 27, 2007
Reality and responsibility: a commentary on the treatment of pain and suffering in a drug-using societySteven D Passik, Howard Heit, Kenneth L Kirsh
Journal of Opioid Management|January 9, 2018
Reality and responsibility revisited: Stakeholder accountability in the effort to develop safer opioidsSteven D Passik, Howard A Heit, Michael DeGeorge
Journal of Opioid Management|December 2, 2009
Chronic opioid therapy issues associated with opioid abuse potentialHoward S Smith, Kenneth L Kirsh, Steven D Passik
Journal of Opioid Management|March 10, 2015
FDA/DEA/PDMP/UDT: alphabet soup or sensible and integrated risk management?Steven D Passik, Kenneth L Kirsh, Robert K Twillman
Journal of Opioid Management|January 23, 2023
Preliminary validation of the Diversion Risk Scale (DRS): Using environmental and individual factors to predict opioid-related diversion eventsTed Jones, Todd M Moore, Diana S Meske, et al.
Journal of Opioid Management|March 10, 2015
Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implicationsKenneth L Kirsh, Paul J Christo, Howard Heit, et al.
Journal of Opioid Management|January 11, 2021
Concomitant use of benzodiazepines in chronic pain patients adherent to extended-release tapentadol or oxycodone treatment-A retrospective claims analysisVladimir Zah, Martina Imro, Simona Tatovic, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Opioid Management|August 28, 2014
Opioid analgesics: does potency matter?Steven D Passik, Lynn Webster
Journal of Opioid Management|August 10, 2011
Current status and evolving role of abuse-deterrent opioids in managing patients with chronic painLynn Webster, Barbara St Marie, Bill McCarberg, et al.
Journal of Opioid Management|December 15, 2011
A comparison of methods of administering the opioid risk toolTed Jones, Steven D Passik
Journal of Opioid Management|February 27, 2007
Reality and responsibility: a commentary on the treatment of pain and suffering in a drug-using societySteven D Passik, Howard Heit, Kenneth L Kirsh
Journal of Opioid Management|January 9, 2018
Reality and responsibility revisited: Stakeholder accountability in the effort to develop safer opioidsSteven D Passik, Howard A Heit, Michael DeGeorge
Journal of Opioid Management|December 2, 2009
Chronic opioid therapy issues associated with opioid abuse potentialHoward S Smith, Kenneth L Kirsh, Steven D Passik
Journal of Opioid Management|March 10, 2015
FDA/DEA/PDMP/UDT: alphabet soup or sensible and integrated risk management?Steven D Passik, Kenneth L Kirsh, Robert K Twillman
Journal of Opioid Management|January 23, 2023
Preliminary validation of the Diversion Risk Scale (DRS): Using environmental and individual factors to predict opioid-related diversion eventsTed Jones, Todd M Moore, Diana S Meske, et al.
Journal of Opioid Management|March 10, 2015
Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implicationsKenneth L Kirsh, Paul J Christo, Howard Heit, et al.
Journal of Opioid Management|January 11, 2021
Concomitant use of benzodiazepines in chronic pain patients adherent to extended-release tapentadol or oxycodone treatment-A retrospective claims analysisVladimir Zah, Martina Imro, Simona Tatovic, et al.
Pageof 3